Revenue
$2.23B
Fiscal year ended 2025-12-31Operating income
$42.83M
Fiscal year ended 2025-12-31Free cash flow
$91.80M
Fiscal year ended 2025-12-31ICU MEDICAL INC/DE (ICUI) reported revenue of $2.23B and net income of $732.00K for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ICU MEDICAL INC/DE’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379.37M |
| Cost of revenue | $1.41B | $1.56B | $1.52B | $1.58B | $824.82M | $809.51M | $794.34M | $830.01M | $866.52M | $177.97M |
| Gross profit | $822.04M | $824.78M | $739.87M | $697.76M | $491.49M | $461.50M | $471.86M | $570.03M | $426.10M | $201.40M |
| Operating income | $42.83M | $42.96M | $22.82M | -$42.90M | $123.24M | $98.16M | $107.36M | $29.76M | -$13.29M | $82.94M |
| Net income | $732.00K | -$117.69M | -$29.66M | -$74.29M | $103.14M | $86.87M | $101.04M | $28.79M | $68.64M | $63.08M |
| Research & development | $87.50M | $88.62M | $85.34M | $92.98M | $47.50M | $42.95M | $48.61M | $52.87M | $51.25M | $12.96M |
| Weighted-average diluted shares | shares 24.90M | shares 24.39M | shares 24.09M | shares 23.87M | shares 21.78M | shares 21.59M | shares 21.54M | shares 21.60M | shares 20.86M | shares 17.25M |
| Pretax income | $4.36M | -$66.01M | -$78.30M | Unavailable | Unavailable | $97.49M | $114.71M | $22.37M | $51.28M | $85.16M |
| Income tax expense | $2.44M | $51.68M | -$48.64M | -$40.12M | $20.05M | $10.62M | $13.67M | -$6.42M | -$17.36M | $22.08M |
| Diluted EPS | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 |
| Selling, general & administrative | $625.21M | $638.76M | $606.69M | $608.34M | $302.58M | $283.95M | $276.98M | $320.00M | $302.17M | $89.43M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | $208.78M | $552.83M | $396.10M | $268.67M | $344.78M | $290.07M | $445.08M |
| Total assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $704.69M |
| Current assets | $1.19B | $1.44B | $1.22B | $1.24B | $1.03B | $920.78M | $882.20M | $927.04M | $864.66M | $569.10M |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $498.86M | $556.18M | $481.84M | $494.56M | $200.78M | $195.49M | $248.47M | $249.29M | $210.29M | $40.54M |
| Total equity incl. NCI | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B | $1.50B | $1.38B | $1.26B | $1.20B | $660.16M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $615.86M | $584.68M | $709.36M | $696.01M | $290.24M | $314.93M | $337.64M | $311.16M | $288.66M | $49.26M |
| Accounts receivable | $180.52M | $182.83M | $161.57M | $221.72M | $105.89M | $124.09M | $202.22M | $176.30M | $112.70M | $56.16M |
| Goodwill | $1.50B | $1.43B | $1.47B | $1.45B | $43.44M | $33.00M | $31.24M | $11.20M | $12.36M | $5.58M |
| Long-term debt | $1.27B | $1.53B | $1.58B | $1.62B | $0 | Unavailable | Unavailable | Unavailable | Unavailable | $0 |
| Accounts payable | $154.37M | $148.02M | $150.03M | $215.90M | $81.13M | $71.86M | $128.63M | $120.47M | $78.23M | $14.64M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $179.85M | $204.03M | $166.20M | -$62.13M | $267.54M | $222.75M | $101.92M | $160.22M | $154.42M | $89.94M |
| Capital expenditures | $88.04M | $79.37M | $83.89M | $90.31M | $68.54M | $92.00M | $97.31M | $92.72M | $74.48M | $23.36M |
| Investing cash flow | $122.23M | -$88.96M | -$87.95M | -$1.91B | -$90.69M | -$98.14M | -$166.89M | -$103.37M | -$266.87M | $16.28M |
| Financing cash flow | -$311.52M | -$55.80M | -$35.98M | $1.64B | -$16.87M | -$40.00K | -$10.91M | $8.02M | -$44.35M | $2.47M |
| Net change in cash | -$603.00K | $54.34M | $45.44M | -$344.04M | $156.73M | $127.43M | -$76.11M | $54.71M | -$155.01M | $108.92M |
| Stock-based compensation | $55.76M | $46.88M | $40.56M | $36.02M | $27.34M | $23.95M | $21.92M | $24.24M | $19.35M | $15.24M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $8.77M | $11.99M | $9.35M | $10.88M | $8.34M | $12.88M | $18.64M | $6.25M | $4.06M | $17.24M |
| Depreciation & amortization | $200.74M | $219.51M | $228.77M | $235.15M | $89.70M | $85.63M | $76.92M | $74.74M | $66.57M | $19.05M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $91.80M | $124.66M | $82.31M | -$152.44M | $199.00M | $130.75M | $4.61M | $67.50M | $79.94M | $66.58M |
| Gross margin | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% | 36.3% | 37.3% | 40.7% | 33.0% | 53.1% |
| Operating margin | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% | 7.7% | 8.5% | 2.1% | -1.0% | 21.9% |
| FCF margin | 4.1% | 5.2% | 3.6% | -6.7% | 15.1% | 10.3% | 0.4% | 4.8% | 6.2% | 17.6% |
| SBC / revenue | 2.5% | 2.0% | 1.8% | 1.6% | 2.1% | 1.9% | 1.7% | 1.7% | 1.5% | 4.0% |
| Current ratio | 2.39x | 2.59x | 2.53x | 2.50x | 5.13x | 4.71x | 3.55x | 3.72x | 4.11x | 14.04x |
| Revenue YoY growth | -6.3% | 5.4% | -0.9% | 73.2% | 3.6% | 0.4% | -9.6% | 8.3% | 240.7% | Unavailable |
| Net margin | 0.0% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% |
| R&D / revenue | 3.9% | 3.7% | 3.8% | 4.1% | 3.6% | 3.4% | 3.8% | 3.8% | 4.0% | 3.4% |
| CapEx / revenue | 3.9% | 3.3% | 3.7% | 4.0% | 5.2% | 7.2% | 7.7% | 6.6% | 5.8% | 6.2% |
| Long-term debt / equity | 0.60x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 55.9% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -28.7% | -33.9% | 25.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ICUI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.